Gemzar
Links shared publicly online about this topic
Teva, APP enter agreement for launch of generic Gemzar
news-medical.net — “Teva Pharmaceutical Industries Ltd. and APP Pharmaceuticals, Inc. announced today the commercial launch of Gemcitabine HCI for Injection in 200 mg and 1 g single dose vials, the generic version of Gemzar®, in the United States, pursuant to a commercialization, manufacture and supply agreement signed by the two companies.” View full resource at news-medical.net
Most Recently Shared on January 27, 2011 at 8:44 am By:
Medicare News: Teva, APP enter agreement for launch of generic Gemzar: Teva Pharmaceutical Industries Ltd. and A... http://bit.ly/fO4avJ
Pharmacy Europe - Generic Gemzar may appear soon
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on July 30, 2010 at 11:40 am By:
Generic Gemzar may appear soon: Eli Lily soon to lose market exclusivity over Gemzar cancer drug (Source: Pharmacy... http://bit.ly/aPboY1
Court ruling could pave way for Gemzar generics
links.assetize.com — “Assetize allows publishers to brand and monetize shared links.” View full resource at links.assetize.com
Most Recently Shared on July 29, 2010 at 4:44 am By:
Court ruling could pave way for Gemzar generics http://bit.ly/bd19ee
Teva Provides Update On Gemzar(R) Litigation
medicalnewstoday.com — “Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. District Court for the Southern District of Indiana issued a decision yesterday on two patents for Gemzar® (gemcitabi” View full resource at medicalnewstoday.com
Most Recently Shared on April 7, 2010 at 12:37 am By:
Teva Provides Update On Gemzar(R) Litigation Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. .. http://dld.bz/2MZ
Gemzar | Drug safety information | Monitoring several patients | MediGuard
mediguard.org — “Gemzar | Drug safety information | Monitoring several patients | MediGuard” View full resource at mediguard.org
Most Recently Shared on March 19, 2011 at 9:17 pm By:
Real outcomes of 108513176 #gemzar users tracking now on MediGuard.org, http://tinyurl.com/4aj4kqh
Eli Lilly Loses Appeal in Gemzar Patent Case - WSJ.com
online.wsj.com — “A federal appeals court ruled Wednesday that an Eli Lilly Co. patent for anti-cancer drug Gemzar is invalid, a decision that may clear the way for generic competition to the drug late this year.” View full resource at online.wsj.com
Most Recently Shared on July 29, 2010 at 12:45 am By:
WSJ: Eli Lilly Loses Appeal in Gemzar Patent Case. http://bit.ly/dgqvcy
Court ruling could pave way for Gemzar generics http://bit.ly/b44UjV
health.yahoo.net — “Court ruling could pave way for Gemzar generics http://bit.ly/b44UjV” View full resource at health.yahoo.net
Most Recently Shared on July 29, 2010 at 4:10 am By:
Court ruling could pave way for Gemzar generics http://bit.ly/b44UjV
Court ruling could pave way for Gemzar generics http://link.reuters.com/wam22n
reuters.com — “Court ruling could pave way for Gemzar generics http://link.reuters.com/wam22n” View full resource at reuters.com
Most Recently Shared on July 29, 2010 at 4:06 am By:
Court ruling could pave way for Gemzar generics http://link.reuters.com/wam22n
UPDATE 1-U.S. court upholds patent on Gemzar cancer drug | Reuters
reuters.com — “NEW YORK, April 1 (Reuters) - An Indiana federal court upheld the main patent on Eli Lilly and Co's Gemzar cancer drug, protecting the blockbuster product's U.S. marketing exclusivity through” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 8:51 pm By:
US court upholds patent on Gemzar cancer drug. http://bit.ly/dvkh0Q
Teva, APP Pharmaceuticals to launch generic version of Eli Lilly's Gemzar - FirstWord
firstwordplus.com — “Teva, APP Pharmaceuticals to launch generic version of Eli Lilly's Gemzar - FirstWord” View full resource at firstwordplus.com
Most Recently Shared on January 26, 2011 at 5:13 pm By:
RT @fwpharma: Teva, APP Pharmaceuticals to launch generic version of Eli Lilly's Gemzar http://bit.ly/eRxkOm
Court ruling could pave way for Gemzar generics: NEW YORK (Reuters) - A decision by a U.S. appeals court could pav... http://bit.ly/by5gxa
reuters.com — “Court ruling could pave way for Gemzar generics: NEW YORK (Reuters) - A decision by a U.S. appeals court could pav... http://bit.ly/by5gxa” View full resource at reuters.com
Most Recently Shared on July 29, 2010 at 4:22 am By:
Court ruling could pave way for Gemzar generics: NEW YORK (Reuters) - A decision by a U.S. appeals court could pav... http://bit.ly/by5gxa
Court ruling could pave way for Gemzar generics: NEW YORK (Reuters) - A decision by a U.S. appeals court could pav... http://bit.ly/8XKPuk
reuters.com — “Court ruling could pave way for Gemzar generics: NEW YORK (Reuters) - A decision by a U.S. appeals court could pav... http://bit.ly/8XKPuk” View full resource at reuters.com
Most Recently Shared on July 29, 2010 at 7:09 am By:
Court ruling could pave way for Gemzar generics: NEW YORK (Reuters) - A decision by a U.S. appeals court could pav... http://bit.ly/8XKPuk
Medical News: Adjuvant Chemo Drugs Equal for Pancreatic Cancer - in Oncology, Chemotherapy from MedPage Today
medpagetoday.com — “Gemcitabine (Gemzar) doesn't improve survival in patients with resected pancreatic cancer compared with other chemotherapy, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on September 8, 2010 at 1:20 pm By:
Adjuvant Chemo Drugs Equal for Pancreatic Cancer: Gemcitabine (Gemzar) doesn't improve survival in patients w... http://bit.ly/duvekq #drug
Medical News: Chemo Duo Called New Standard for Biliary CA - in Hematology/Oncology, Chemotherapy from MedPage Today
medpagetoday.com — “Adding cisplatin to standard gemcitabine (Gemzar) extends survival in biliary tract cancer without added toxicity, according to results of a phase III clinical trial.” View full resource at medpagetoday.com
Most Recently Shared on April 7, 2010 at 10:29 pm By:
Chemo Duo Called New Standard for Biliary CA (CME/CE, with audio) http://bit.ly/b73yZM
Medical News: ECCO-ESMO: Combo Looks Good for Later Breast Cancer Tx - in Meeting Coverage, ECCO-ESMO from MedPage Today
medpagetoday.com — “STOCKHOLM -- Adding the PARP inhibitor iniparib to gemcitabine (Gemzar) plus carboplatin (Paraplatin) may benefit triple-negative metastatic breast cancer patients when used as second- or third-line t” View full resource at medpagetoday.com
Most Recently Shared on September 29, 2011 at 9:53 pm By:
ECCO-ESMO: Combo Looks Good for Later Breast Cancer Tx (CME/CE) http://t.co/oB0QBkVq
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Medicare news via News-Medical.Net
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Healthy Society
Health news, If I'd known I was going to live so long, I'd have taken better care of myself. , don't make the same mistake.
Advertisement

